AP-2[alpha] suppresses skeletal myoblast proliferation and represses fibroblast growth factor receptor 1 promoter activity

• Published in: Experimental cell research Vol. 316; no. 2; p. 194
• Main Authors: Mitchell, Darrion L, DiMario, Joseph X
• Format: Journal Article
• Language: English
• Published: New York Elsevier BV 15.01.2010
• Subjects: 60 APPLIED LIFE SCIENCES; CELL PROLIFERATION; Cellular biology; CHROMATIN; Developmental biology; FIBROBLASTS; Gene expression; GENE REGULATION; GROWTH FACTORS; IN VITRO; Musculoskeletal system; MUTAGENESIS; Mutation; MUTATIONS; MYOBLASTS; PROMOTERS; RECEPTORS; TRANSCRIPTION FACTORS
• ISSN: 0014-4827; 1090-2422
• DOI: 10.1016/j.yexcr.2009.08.008

Skeletal muscle development is partly characterized by myoblast proliferation and subsequent differentiation into postmitotic muscle fibers. Developmental regulation of expression of the fibroblast growth factor receptor 1 (FGFR1) gene is required for normal myoblast proliferation and muscle formation. As a result, FGFR1 promoter activity is controlled by multiple transcriptional regulatory proteins during both proliferation and differentiation of myogenic cells. The transcription factor AP-2[alpha] is present in nuclei of skeletal muscle cells and suppresses myoblast proliferation in vitro. Since FGFR1 gene expression is tightly linked to myoblast proliferation versus differentiation, the FGFR1 promoter was examined for candidate AP-2[alpha] binding sites. Mutagenesis studies indicated that a candidate binding site located at -1035 bp functioned as a repressor cis-regulatory element. Furthermore, mutation of this site alleviated AP-2[alpha]-mediated repression of FGFR1 promoter activity. Chromatin immunoprecipitation studies demonstrated that AP-2[alpha] interacted with the FGFR1 promoter in both proliferating myoblasts and differentiated myotubes. In total, these results indicate that AP-2[alpha] is a transcriptional repressor of FGFR1 gene expression during skeletal myogenesis. [PUBLICATION ABSTRACT]